Skip to main content
. 2015 Jun 25;6(27):23523–23532. doi: 10.18632/oncotarget.4395

Figure 4. Thrombotic risk assessment in the normal tissue of the tTF-pHLIP-treated mice.

Figure 4

Histological analysis of various normal organs and tumor of MDA-MB-231 tumor-bearing mice 24 hours after treatment with tTF-pHLIP. Sections of heart, liver, spleen, lung, kidney and tumor were stained with hematoxylin and eosin (H&E). Thrombosis was only found in the blood vessels of the tumor, as indicated by the arrows.